000153 丰原药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)1.7274.8228.2298.8058.900
总资产报酬率 ROA (%)0.7092.0383.5393.5953.622
投入资产回报率 ROIC (%)0.9462.7785.0655.2655.242

边际利润分析
销售毛利率 (%)22.89918.37421.76325.70828.228
营业利润率 (%)5.3183.2674.7874.9885.047
息税前利润/营业总收入 (%)5.9934.0825.5475.6295.799
净利润/营业总收入 (%)4.3592.4573.6793.6793.770

收益指标分析
经营活动净收益/利润总额(%)93.29392.80574.50982.30276.544
价值变动净收益/利润总额(%)-0.2704.7181.886-0.7357.327
营业外收支净额/利润总额(%)-0.036-0.7011.7400.7630.096

偿债能力分析
流动比率 (X)0.8970.8820.8980.9450.886
速动比率 (X)0.6710.6530.6270.6600.588
资产负债率 (%)58.98057.98156.46056.30460.737
带息债务/全部投入资本 (%)38.69737.58731.78427.44836.839
股东权益/带息债务 (%)140.348147.162189.414229.778153.594
股东权益/负债合计 (%)68.87571.72376.12376.41763.677
利息保障倍数 (X)8.8514.8758.2099.3347.765

营运能力分析
应收账款周转天数 (天)110.15189.79372.51462.47260.872
存货周转天数 (天)79.31865.00062.64872.12584.810